Skip to content

Transcat stock

TRNSNASDAQ

Transcat, Inc., IndustrialsISIN US8935291075

$106.33▲ $1.21 (+1.2%)Closing price of 12 Nov 2026

56Score 56 out of 100, Neutral

Turn on early warning

Price and trend

85 / 100

Price history

+91% in one year

The chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Above the 200-day line: the price is 27% above it.

Trend change

Since March 2026 the 50-day line has been above the 200-day line; the trend has turned up.

Momentum

Overheated: the price has risen very quickly lately (RSI 72).

Distance to the high

The price is 2.9% below its 52-week high. Largest decline in 20 years: 64% (July 2024 to December 2025).

Chart figures for advanced users
SMA 50$88.64
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$83.43
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)72
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$52.06
The lowest closing price of the last twelve months.
Resistance$109.56
The highest closing price of the last twelve months.
Market cap
$988.64M
Div. yield
no dividend
218.7
earnings collapsed, on expected earnings 47.7
47.2
on earnings for the next twelve months ($2.23 per share)
Fair value
$51.33

Snapshot

Computed from the data by fixed rules, no AI

  • Transcat, Inc. belongs to the Specialty Business Services industry (United States) and, with a market value of $1B, is number 33 of 44 companies in its industry on MEQIRI.
  • In fiscal 2026 it reported revenue of $331.88M (up 19.2% year on year) and earnings of $5.38M (down 63%).
  • For fiscal 2027, analysts expect on average revenue of $380.01M (up 14.5%) and adjusted earnings per share of $2.05 (up 32.5%).
Show more
  • MEQIRI Score 56 out of 100 (Neutral): rank 687 of 1023 in Industrials, median 61.
  • The P/E is 221.2 because earnings over the last twelve months collapsed; on the expected earnings of the next twelve months it is 47.7 (Specialty Business Services median 20.8). The P/E therefore does not count in the score.
  • Our model puts fair value at $51.33, with the price 105% above it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Earnings turn into cashFree cash flow above 500% of earnings over the last 12 months.Fundamentals 80
  • Consistently profitableProfit in all 10 fiscal years from 2017 to 2026.Fundamentals 80

Weaknesses

  • Above fair valuePrice 105% above the fair value of $51.33.Valuation 23
  • DilutionShare count up 26% since 2021.Capital allocation 22
  • Margin fallingOperating margin 4%, average of the prior years 6.9% (to 2025).Profitability 25
56/ 100
MEQIRI Score
Neutral

Its standout strengths are momentum and technical analysis, while valuation and capital allocation hold the score back.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

Fundamentals are strong, with stable profits and strong cash generation.

Profit consistency100% of years
Cash conversion (free cash flow to earnings, 12 months)above 500%
ROIC (12 months)1.9%
Positive free cash flow100% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk low

How well MEQIRI warns

One of the 30% with the lowest crash risk among smaller stocks.

From 2016 to 2025, 14 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What drives the risk

  • price up very strongly over the past year

What lowers it

  • price near its 52-week high
  • solid fundamentals
  • stable momentum

Valuation

Valuation signal

Significantly overvalued
Price
$105.12
Fair value
$51.33
Gap to fair value
+105%

Closing price of 11 Nov 2026, used by the daily score.

In our model the price counts as cheap below $36.67 and expensive above $85.56 (uncertainty high, based on the price swings of the past year).

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $42.74, at 7.8% it would be $64.23.

Valuation metrics

14.78
28.2
Fair value (model)
$51.33

From the cash-flow model alone; after a one-off collapse in earnings there is no industry value.

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

20 years

In the twelve months to 26 Sep 2026, revenue rose 19.3% on the twelve months before. Revenue has grown solidly since 2007, at about 9% per year.

Margins

20 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2026: gross 33%, operating 4%, net 2%.

Debt & balance sheet

latest quarter
0.49
2.4x
2.57
Cash & equivalents
$5.76M

Debt is moderate, but interest coverage is weak. Keep an eye on the interest burden and refinancing.

Earnings

Next earnings
2 Feb 2027in 82 days
Last reported
3 Nov 2026EPS reported $0.64 (expected $0.45)above expectations

Analyst estimates

Analysts have raised their 2027 earnings estimate by 8.4% since 15 Oct 2026.

Fiscal 20274 analysts
Earnings per share
$2.05+8.4%
Revenue
$380.01M+1.9%
Fiscal 20284 analysts
Earnings per share
$2.33+7.6%
Revenue
$408.52M+2.7%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook confirmed

Share price after the results: +4.7%

No change in the figures; management now confidently expects high-single-digit organic growth for the full year.

Supporting passage from the call, verbatim
“I guess, the one word that maybe changed as it relates to the full year is you now confidently expect high single-digit organic growth and just want to sort of get your feedback on whether that's a little bit of a under-the-radar tone shift as well.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 4 Aug 2026 (fiscal Q1 2027), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases

2 insiders bought on the open market in the last 6 months, $329,030 in total. 2 insiders sold, $673,371 in total.

Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.

  • Irick Jaime APurchase

    5 Nov 2026, President and CEO

    Shares
    2,275
    Price
    $101.26
    Value
    $230,367
  • Dominach Oksana S.Sale

    2 Sept 2026, Board

    Shares
    7,312
    Price
    $85.60
    Value
    $625,876
  • Gillette Christopher P.Sale

    7 Aug 2026, Board

    Shares
    504
    Price
    $94.23
    Value
    $47,494
Show 1 more
  • Cairns Craig D.Purchase

    6 Aug 2026, Board

    Shares
    1,050
    Price
    $93.97
    Value
    $98,663

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

What happened at Transcat

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

1023 rated companies in Industrials

Rank 687 of 1023
687/ 1023
This company
56
Sector median
61

Categories against the sector median

ProfitabilityMedian of 1,023 companies25 (median 53)28 below the median
GrowthMedian of 1,023 companies49 (median 63)14 below the median
FundamentalsMedian of 1,023 companies80 (median 71)9 above the median
ValuationMedian of 977 companies with a value23 (median 64)41 below the median
StabilityMedian of 1,023 companies61 (median 65)4 below the median
Capital allocationMedian of 1,023 companies22 (median 55)33 below the median
Technical analysisMedian of 1,023 companies85 (median 60)25 above the median
MomentumMedian of 1,023 companies96 (median 59)37 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Specialty Business Services

The next larger and next smaller companies by market value

All 44 Specialty Business Services stocks

ETFs that hold Transcat

Held by 9 ETFs on Xetra. Shown per index: the ETF with the largest weight.

Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2026, period end 28 Mar 2026
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 28 Oct 2026)
  • Valuation signal Overvalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy